Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""ANASTROZOLE"" wg kryterium: Temat


Tytuł :
Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation.
Autorzy :
Xulu KR; School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg 2193, South Africa.
Augustine TN; School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg 2193, South Africa.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 16; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation*
Epithelial-Mesenchymal Transition*
Anastrozole/*adverse effects
Antineoplastic Agents, Hormonal/*adverse effects
Breast Neoplasms/*drug therapy
Platelet Aggregation Inhibitors/*adverse effects
Thrombophilia/*prevention & control
Adult ; Anastrozole/administration & dosage ; Anastrozole/therapeutic use ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Hormonal/therapeutic use ; Aspirin/administration & dosage ; Aspirin/adverse effects ; Aspirin/therapeutic use ; Breast Neoplasms/complications ; Cells, Cultured ; Clopidogrel/administration & dosage ; Clopidogrel/adverse effects ; Clopidogrel/therapeutic use ; Drug Interactions ; Female ; Humans ; Imines/administration & dosage ; Imines/adverse effects ; Imines/therapeutic use ; MCF-7 Cells ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/therapeutic use ; Pyridines/administration & dosage ; Pyridines/adverse effects ; Pyridines/therapeutic use ; Thrombin/metabolism ; Thrombophilia/drug therapy ; Thrombophilia/etiology
Czasopismo naukowe
Tytuł :
Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitors.
Autorzy :
Streff A; Vanderbilt University, Nashville, TN, USA.
Chu-Pilli M; University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ, USA.
Stopeck A; Department of Medicine, Hematology/Oncology, Stony Brook University, Stony Brook, NY, USA.
Chalasani P; University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ, USA. .
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Jan; Vol. 29 (1), pp. 187-191. Date of Electronic Publication: 2020 Apr 23.
Typ publikacji :
Clinical Trial, Phase II; Journal Article
MeSH Terms :
Anastrozole/*therapeutic use
Aromatase Inhibitors/*therapeutic use
Breast Neoplasms/*drug therapy
Estradiol/*blood
Estrogen Receptor Modulators/*therapeutic use
Estrogens/*adverse effects
Administration, Intravaginal ; Anastrozole/adverse effects ; Estrogen Receptor Modulators/adverse effects ; Estrogens/administration & dosage ; Estrogens/therapeutic use ; Female ; Humans ; Middle Aged ; Postmenopause ; Prospective Studies ; Retrospective Studies ; Vaginal Diseases/chemically induced ; Vaginal Diseases/drug therapy
Czasopismo naukowe
Tytuł :
Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis.
Autorzy :
Huang X; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Weng X; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Lin S; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Liu Y; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Luo S; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Wang H; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Ming WK; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, Guangdong, China .; Harvard Medical School, Harvard University, Boston, MA, United States.
Huang P; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China .
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2020 Aug 30; Vol. 10 (8), pp. e036107. Date of Electronic Publication: 2020 Aug 30.
Typ publikacji :
Journal Article
MeSH Terms :
Anastrozole/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Breast Neoplasms/*drug therapy
Fulvestrant/*therapeutic use
Anastrozole/administration & dosage ; Anastrozole/economics ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Hormonal/economics ; Breast Neoplasms/economics ; Breast Neoplasms/pathology ; Cost-Benefit Analysis ; Drug Costs ; Drug Therapy, Combination/economics ; Drug Therapy, Combination/methods ; Female ; Fulvestrant/administration & dosage ; Fulvestrant/economics ; Health Care Costs ; Humans ; Markov Chains ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.
Autorzy :
Cairns J; Department of Molecular Pharmacology and Experimental Therapeutics.
Ingle JN; Division of Medical Oncology, and.
Dudenkov TM; Department of Molecular Pharmacology and Experimental Therapeutics.
Kalari KR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Carlson EE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Na J; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Buzdar AU; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Robson ME; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ellis MJ; Baylor Cancer Center, Houston, Texas, USA.
Goss PE; Massachusetts General Hospital, Boston, Massachusetts, USA.
Shepherd LE; NCIC Clinical Trials Group, Kingston, Ontario, Canada.
Goodnature B; Patient advocate, Mayo Clinic Breast Cancer Specialized Program of Research Excellence, Rochester, Minnesota, USA.
Goetz MP; Division of Medical Oncology, and.
Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics.
Li H; Department of Molecular Pharmacology and Experimental Therapeutics.
Bari MG; Department of Molecular Pharmacology and Experimental Therapeutics.
Wang L; Department of Molecular Pharmacology and Experimental Therapeutics.
Pokaż więcej
Źródło :
JCI insight [JCI Insight] 2020 Aug 20; Vol. 5 (16). Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Polymorphism, Single Nucleotide*
Anastrozole/*pharmacology
Aromatase Inhibitors/*pharmacokinetics
Breast Neoplasms/*drug therapy
Membrane Proteins/*genetics
Tumor Suppressor Proteins/*genetics
Anastrozole/administration & dosage ; Anastrozole/pharmacokinetics ; Antineoplastic Agents, Hormonal/pharmacokinetics ; Antineoplastic Agents, Hormonal/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Aromatase/genetics ; Breast Neoplasms/genetics ; Breast Neoplasms/mortality ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Estradiol/administration & dosage ; Estradiol/pharmacology ; Estrogen Receptor alpha/metabolism ; Female ; Genome-Wide Association Study ; Humans ; Pharmacogenetics ; Postmenopause
Czasopismo naukowe
Tytuł :
Biophysical Insight into the Interaction of Human Lysozyme with Anticancer Drug Anastrozole: A Multitechnique Approach.
Autorzy :
Almutairi FM; Physical Biochemistry Research Laboratory, Biochemistry Department, Faculty of Science, University of Tabuk, P.O. Box 741, Tabuk 71491, Saudi Arabia.
Ajmal MR; Physical Biochemistry Research Laboratory, Biochemistry Department, Faculty of Science, University of Tabuk, P.O. Box 741, Tabuk 71491, Saudi Arabia.
Alawy AIA; Physical Biochemistry Research Laboratory, Biochemistry Department, Faculty of Science, University of Tabuk, P.O. Box 741, Tabuk 71491, Saudi Arabia.
Khan RH; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India.
Abdelhameed AS; Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło :
TheScientificWorldJournal [ScientificWorldJournal] 2020 Aug 25; Vol. 2020, pp. 8363685. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Molecular Docking Simulation*
Molecular Dynamics Simulation*
Spectrum Analysis*
Anastrozole/*chemistry
Antineoplastic Agents/*chemistry
Muramidase/*chemistry
Anastrozole/pharmacology ; Antineoplastic Agents/pharmacology ; Enzyme Activation ; Humans ; Molecular Conformation ; Molecular Structure ; Muramidase/metabolism ; Protein Binding ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies.
Autorzy :
Smith SG; Leeds Institute of Health Science, University of Leeds, Clarendon Way, Leeds, LS2 9NL, UK. .; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. .
Sestak I; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
Morris MA; Leeds Institute for Data Analytics, School of Medicine, University of Leeds, Leeds, UK.
Harvie M; Prevent Breast Cancer Unit, Nightingale Breast Screening Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Howell A; Prevent Breast Cancer Unit, Nightingale Breast Screening Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
Forbes J; Breast Cancer Trials, Newcastle, Australia.
Cuzick J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jul; Vol. 188 (1), pp. 215-223. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Breast Neoplasms*
Carcinoma, Intraductal, Noninfiltrating*
Anastrozole ; Body Mass Index ; Female ; Humans ; Incidence ; Risk Factors ; Tamoxifen
Czasopismo naukowe
Tytuł :
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials.
Autorzy :
Toi M; Breast Cancer Unit, Graduate School of Medicine, Kyoto University Hospital, Kyoto University, Kyoto, Japan.
Inoue K; Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan.
Masuda N; National Hospital Organization Osaka National Hospital, Osaka, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Hae Park I; Division of Hematology and Medical Oncology, Department of Internal Medicine, National Cancer Center, Goyang, Korea.
Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Chen SC; Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University Medical College Taoyuan, Taoyuan, Taiwan.
Enatsu S; Eli Lilly and Company, Tokyo, Japan.
Turner PK; Eli Lilly and Company, Indianapolis, IN, USA.
André VAM; Eli Lilly and Company, Paris, France.
Hardebeck MC; Eli Lilly and Company, Indianapolis, IN, USA.
Sakaguchi S; Eli Lilly and Company, Tokyo, Japan.
Goetz MP; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Sledge GW Jr; Stanford University, Stanford, CA, USA.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Jun; Vol. 112 (6), pp. 2381-2392. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Aminopyridines/*administration & dosage
Aromatase Inhibitors/*administration & dosage
Benzimidazoles/*administration & dosage
Breast Neoplasms/*drug therapy
Fulvestrant/*administration & dosage
Aminopyridines/adverse effects ; Aminopyridines/pharmacokinetics ; Anastrozole/administration & dosage ; Anastrozole/adverse effects ; Anastrozole/pharmacokinetics ; Aromatase Inhibitors/adverse effects ; Aromatase Inhibitors/pharmacokinetics ; Benzimidazoles/adverse effects ; Benzimidazoles/pharmacokinetics ; Breast Neoplasms/blood ; Breast Neoplasms/genetics ; Diarrhea/chemically induced ; Diarrhea/epidemiology ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Fulvestrant/adverse effects ; Fulvestrant/pharmacokinetics ; Humans ; Letrozole/administration & dosage ; Letrozole/adverse effects ; Letrozole/pharmacokinetics ; Neutropenia/chemically induced ; Neutropenia/epidemiology ; Receptor, ErbB-2/genetics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial.
Autorzy :
Acién P; Department/Division of Gynecology, Miguel Hernández University, San Juan Campus, 03550, San Juan, Alicante, Spain. .; Obstetrics and Gynecology Service, San Juan University Hospital, 03550, San Juan, Alicante, Spain. .; Departamento/Area de Ginecología, Facultad de Medicina de La Universidad 'Miguel Hernández', Campus de San Juan, 03550, Alicante, Spain. .
Velasco I; Obstetrics and Gynecology Service, San Juan University Hospital, 03550, San Juan, Alicante, Spain.
Acién M; Department/Division of Gynecology, Miguel Hernández University, San Juan Campus, 03550, San Juan, Alicante, Spain.; Obstetrics and Gynecology Service, San Juan University Hospital, 03550, San Juan, Alicante, Spain.
Pokaż więcej
Źródło :
BMC women's health [BMC Womens Health] 2021 May 20; Vol. 21 (1), pp. 211. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Contraceptive Agents, Female*
Endometriosis*/diagnostic imaging
Endometriosis*/drug therapy
Intrauterine Devices*
Intrauterine Devices, Medicated*
Anastrozole/therapeutic use ; Female ; Humans ; Levonorgestrel/therapeutic use ; London ; Prospective Studies
Czasopismo naukowe
Tytuł :
The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain.
Autorzy :
Erken N; Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Dost Gunay FS; Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Soysal P; Department of Geriatric Medicine, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Isik AT; Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Pokaż więcej
Źródło :
Clinical interventions in aging [Clin Interv Aging] 2020 May 19; Vol. 15, pp. 691-693. Date of Electronic Publication: 2020 May 19 (Print Publication: 2020).
Typ publikacji :
Case Reports
MeSH Terms :
Anastrozole*/administration & dosage
Anastrozole*/adverse effects
Cognition Disorders*/diagnosis
Cognition Disorders*/drug therapy
Cognition Disorders*/etiology
Radiotherapy*/adverse effects
Radiotherapy*/methods
Breast Neoplasms/*therapy
Cognition/*drug effects
Curcumin/*administration & dosage
Aged ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Hormonal/adverse effects ; Breast Neoplasms/pathology ; Female ; Geriatric Assessment/methods ; Humans ; Mastectomy, Segmental/methods ; Nootropic Agents/administration & dosage ; Treatment Outcome
Raport
Tytuł :
First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis.
Autorzy :
Liao W; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China.; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China.
Huang J; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China.; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China.
Wu Q; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China.; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China.
Wen F; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China.; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China.
Zhang N; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China.; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China.
Zhou K; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China.; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China.
Bai L; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China.; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China.
Li Q; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, 610041, China. .; West China Biomedical Big Data Center, Sichuan University, Chengdu, 610041, China. .
Pokaż więcej
Źródło :
Breast cancer (Tokyo, Japan) [Breast Cancer] 2020 May; Vol. 27 (3), pp. 399-404. Date of Electronic Publication: 2019 Dec 18.
Typ publikacji :
Journal Article
MeSH Terms :
Cost-Benefit Analysis*
Postmenopause*
Anastrozole/*economics
Antineoplastic Agents, Hormonal/*economics
Breast Neoplasms/*economics
Fulvestrant/*economics
Anastrozole/therapeutic use ; Antineoplastic Agents, Hormonal/therapeutic use ; Breast Neoplasms/drug therapy ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Follow-Up Studies ; Fulvestrant/therapeutic use ; Humans ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism
Czasopismo naukowe
Tytuł :
Exemestane induced cholestatic liver injury - A case report.
Autorzy :
Fritzsche D; Seattle Cancer Care Alliance, University of Washington Medicine, Seattle, WA, USA.
Indorf A; Seattle Cancer Care Alliance, University of Washington Medicine, Seattle, WA, USA.
Miske A; Seattle Cancer Care Alliance, University of Washington Medicine, Seattle, WA, USA.
Banda K; Seattle Cancer Care Alliance, University of Washington Medicine, Seattle, WA, USA.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Jun; Vol. 27 (4), pp. 1029-1032. Date of Electronic Publication: 2020 Sep 21.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Androstadienes/*adverse effects
Aromatase Inhibitors/*adverse effects
Chemical and Drug Induced Liver Injury/*diagnosis
Cholestasis/*chemically induced
Cholestasis/*diagnosis
Aged ; Anastrozole/therapeutic use ; Breast Neoplasms/drug therapy ; Chemical and Drug Induced Liver Injury/drug therapy ; Cholestasis/drug therapy ; Female ; Humans
Czasopismo naukowe
Tytuł :
[Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer].
Autorzy :
Iwata T; Dept. of Surgery, Kasugai Municipal Hospital.
Yamaguchi R
Furuta M
Watanabe S
Aizu K
Kobayashi S
Sato F
Fujieda H
Toyoda Y
Kageyama Y
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2021 May; Vol. 48 (5), pp. 701-703.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Inflammatory Breast Neoplasms*
Lung Diseases, Interstitial*/chemically induced
Lung Diseases, Interstitial*/drug therapy
Aged, 80 and over ; Anastrozole ; Female ; Humans ; Trastuzumab/adverse effects
Czasopismo naukowe
Tytuł :
Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.
Autorzy :
Filip-Psurska B; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigl, 53-114 Wroclaw, Poland.
Psurski M; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigl, 53-114 Wroclaw, Poland.
Anisiewicz A; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigl, 53-114 Wroclaw, Poland.
Libako P; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigl, 53-114 Wroclaw, Poland.
Zbrojewicz E; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigl, 53-114 Wroclaw, Poland.
Maciejewska M; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigl, 53-114 Wroclaw, Poland.
Chodyński M; Łukasiewicz Research Network-Industrial Chemistry Institute, 8 Rydygiera, 01-793 Warsaw, Poland.
Kutner A; Department of Bioanalysis and Drug Analysis, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha, 02-097 Warsaw, Poland.
Wietrzyk J; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigl, 53-114 Wroclaw, Poland.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 09; Vol. 22 (5). Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*pharmacology
Breast Neoplasms/*drug therapy
Anastrozole/agonists ; Anastrozole/pharmacology ; Animals ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Calcitriol/analogs & derivatives ; Calcitriol/pharmacology ; Dihydroxycholecalciferols/pharmacology ; Female ; Humans ; MCF-7 Cells ; Mice ; Mice, SCID ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Aromatase inhibitor anastrozole modifies cellular functions in gingival fibroblasts and endothelial cells: possible periodontal complications of aromatase inhibitor treatment.
Autorzy :
Hasegawa S; Division of Oral Biology and Disease Control, Department of Periodontology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Yanagita M; Division of Oral Biology and Disease Control, Department of Periodontology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.; Department of Oral Health, Kobe Tokiwa Junior College, Kobe, Hyogo, Japan.
Tatsumi M; Division of Oral Biology and Disease Control, Department of Periodontology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Yamashita M; Division of Oral Biology and Disease Control, Department of Periodontology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Kitamura M; Division of Oral Biology and Disease Control, Department of Periodontology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Murakami S; Division of Oral Biology and Disease Control, Department of Periodontology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Pokaż więcej
Źródło :
Journal of periodontal research [J Periodontal Res] 2021 Aug; Vol. 56 (4), pp. 828-836. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Journal Article
MeSH Terms :
Aromatase Inhibitors*/adverse effects
Endothelial Cells*
Anastrozole/adverse effects ; Cells, Cultured ; Fibroblasts ; Gingiva ; Humans ; Porphyromonas gingivalis
Czasopismo naukowe
Tytuł :
A novel view of the separate and simultaneous binding effects of docetaxel and anastrozole with calf thymus DNA: Experimental and in silico approaches.
Autorzy :
Dareini M; Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Amiri Tehranizadeh Z; Medicinal Chemistry Department, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: .
Marjani N; Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Taheri R; Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Aslani-Firoozabadi S; Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Talebi A; Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
NayebZadeh Eidgahi N; Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Saberi MR; Medicinal Chemistry Department, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: .
Chamani J; Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran. Electronic address: .
Pokaż więcej
Źródło :
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2020 Mar 05; Vol. 228, pp. 117528. Date of Electronic Publication: 2019 Oct 30.
Typ publikacji :
Journal Article
MeSH Terms :
Computer Simulation*
Anastrozole/*metabolism
DNA/*metabolism
Docetaxel/*metabolism
Anastrozole/chemistry ; Binding, Competitive ; Calorimetry ; DNA/chemistry ; Docetaxel/chemistry ; Kinetics ; Models, Molecular ; Nucleic Acid Denaturation ; Osmolar Concentration ; Scattering, Radiation ; Spectrometry, Fluorescence ; Thermodynamics ; Viscosity
Czasopismo naukowe
Tytuł :
Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
Autorzy :
Mirfakhraee S; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. .; UT Southwestern Medical Center, WCB3 8th Floor, 2001 Inwood Rd, Dallas, TX, 75390, USA. .
Chan AVC Jr; Division of Mineral Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ganji N; Department of Physiology, University of Toronto, Toronto, ON, Canada.
Abramowitz J; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2021 Apr 29; Vol. 15 (1), pp. 207. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Acromegaly*/drug therapy
Breast Neoplasms*/drug therapy
Anastrozole/therapeutic use ; Antineoplastic Agents, Hormonal/adverse effects ; Aromatase Inhibitors/adverse effects ; Chemotherapy, Adjuvant ; Female ; Humans ; Middle Aged ; Nitriles/therapeutic use ; Tamoxifen/therapeutic use
Czasopismo naukowe
Tytuł :
Preventing Breast Cancer Through Identification and Pharmacologic Management of High-Risk Patients.
Autorzy :
Gilman EA; Division of General Internal Medicine, Breast Diagnostic Clinic, Mayo Clinic, Rochester, MN. Electronic address: .
Pruthi S; Division of General Internal Medicine, Breast Diagnostic Clinic, Mayo Clinic, Rochester, MN.
Hofstatter EW; Department of Internal Medicine, Section of Medical Oncology, Smilow Cancer Hospital, Yale University, New Haven, CT.
Mussallem DM; Department of Internal Medicine, Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL.
Pokaż więcej
Źródło :
Mayo Clinic proceedings [Mayo Clin Proc] 2021 Apr; Vol. 96 (4), pp. 1033-1040.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anastrozole/*administration & dosage
Breast Neoplasms/*prevention & control
Estrogen Antagonists/*administration & dosage
Health Personnel/*education
Preventive Medicine/*education
Raloxifene Hydrochloride/*administration & dosage
Selective Estrogen Receptor Modulators/*administration & dosage
Tamoxifen/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/epidemiology ; Curriculum ; Decision Making, Shared ; Education, Medical, Continuing ; Female ; Humans ; Male ; Middle Aged ; Preventive Medicine/methods ; Risk Assessment ; Risk Factors ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Solar photo-Fenton treatment of the anti-cancer drug anastrozole in different aqueous matrices at near-neutral pH: Transformation products identification, pathways proposal, and in silico (Q)SAR risk assessment.
Autorzy :
Sanabria P; Instituto de Química-UFRGS, Av. Bento Gonçalves 9500, CEP 91501-970 Porto Alegre, RS, Brazil.
Scunderlick D; Instituto de Química-UFRGS, Av. Bento Gonçalves 9500, CEP 91501-970 Porto Alegre, RS, Brazil.
Wilde ML; Instituto de Química-UFRGS, Av. Bento Gonçalves 9500, CEP 91501-970 Porto Alegre, RS, Brazil.
Lüdtke DS; Instituto de Química-UFRGS, Av. Bento Gonçalves 9500, CEP 91501-970 Porto Alegre, RS, Brazil.
Sirtori C; Instituto de Química-UFRGS, Av. Bento Gonçalves 9500, CEP 91501-970 Porto Alegre, RS, Brazil. Electronic address: .
Pokaż więcej
Źródło :
The Science of the total environment [Sci Total Environ] 2021 Feb 01; Vol. 754, pp. 142300. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*
Water Pollutants, Chemical*
Anastrozole ; Hydrogen Peroxide ; Hydrogen-Ion Concentration ; Risk Assessment
Czasopismo naukowe
Tytuł :
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Autorzy :
Cuzick J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. Electronic address: .
Sestak I; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK.
Forbes JF; Australia New Zealand Breast Cancer Trials Group Newcastle, University of Newcastle, Calvary Mater Hospital, Waratah, NSW, Australia.
Dowsett M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden, London, UK.
Cawthorn S; Breast Care Centre, Southmead Hospital, Bristol, UK.
Mansel RE; University Department of Surgery, University of Wales College of Medicine, Cardiff, UK.
Loibl S; German Breast Group, Frankfurt, Germany.
Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Evans DG; Prevent Breast Cancer Unit, Nightingale Breast Screening Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Howell A; Prevent Breast Cancer Unit, Nightingale Breast Screening Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Pokaż więcej
Corporate Authors :
IBIS-II investigators
Źródło :
Lancet (London, England) [Lancet] 2020 Jan 11; Vol. 395 (10218), pp. 117-122. Date of Electronic Publication: 2019 Dec 12.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anastrozole/*therapeutic use
Aromatase Inhibitors/*therapeutic use
Breast Neoplasms/*drug therapy
Breast Neoplasms/*prevention & control
Administration, Oral ; Adult ; Aged ; Anastrozole/adverse effects ; Breast Neoplasms/epidemiology ; Breast Neoplasms/mortality ; Carcinoma, Ductal, Breast/drug therapy ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Intraductal, Noninfiltrating/drug therapy ; Carcinoma, Intraductal, Noninfiltrating/pathology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Middle Aged ; Placebos ; Treatment Outcome ; United Kingdom/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies